Search Results 121-130 of 14977 for infliximab

  1. A Study of the Effectiveness of Methotrexate as Initial Treatment and Maintenance of a Steroid Free Remission in Ulcerative Colitis - Mayo Clinic

    ... (infliximab, adalimumab, golimumab) in the past; Primary failure or loss of response to vedolizumab in the past; Intolerance/failure of azathioprine/6-MP ...

  2. Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease - Mayo Clinic

    Maintenance monotherapy: infliximab (at least 8 every 8 weeks), golilumumab (at least monthly), adalilumab (at least every 2 weeks), or certolizumab (at least ...

  3. Ustekinumab-srlf (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Cyclosporine; Dengue Tetravalent Vaccine, Live; Ebola Zaire Vaccine, Live; Infliximab; Influenza Virus Vaccine, Live; Measles Virus Vaccine, Live; Mumps Virus ...

  4. Clinical Trials - TD-1473 for Active Ulcerative Colitis (UC)

    ... infliximab, golimumab, etanercept, or certolizumab within the 60 days prior to Day 1, c) intravenous corticosteroids within the 14 days prior to Day 1, d ...

  5. Baricitinib (oral route) - Side effects & dosage - Mayo Clinic

    Infliximab; Influenza Virus Vaccine, Live; Ixekizumab; Leflunomide; Measles Virus Vaccine, Live; Mumps Virus Vaccine, Live; Nitisinone; Poliovirus Vaccine, Live ...

  6. Ustekinumab (injection route) - Side effects & dosage - Mayo Clinic

    Cyclosporine; Dengue Tetravalent Vaccine, Live; Ebola Zaire Vaccine, Live; Infliximab; Influenza Virus Vaccine, Live; Measles Virus Vaccine, Live; Mumps Virus ...

  7. Examining the clinical presentation and imaging characteristics of cryptogenic multifocal ulcerous stenosing enteritis

    ... infliximab. Recurrence to medical therapy (median of four months after treatment) occurred in six (85.7%) patients. Surgery for refractory intestinal ...

  8. A Study to Assess the Effectiveness and Safety of Golimumab in Pediatric Participants With Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

    Contraindications to the use of golimumab or infliximab or anti-tumor necrosis factor (TNF-alpha) therapy per local prescribing information. Participating ...

  9. Doctors and departments - Mayo Clinic

    Mayo Clinic has made important contributions to the treatment of IBD over the years, including pioneering ileoanal anastomosis (J-pouch surgery) and ...

  10. A Study to Evaluate the Safety and Effectiveness of Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients with Crohn's Disease - Mayo Clinic

    Infliximab: at least 14 weeks treatment at the approved doses for induction and/or maintenance in Crohn´s disease prior to screening for the study. For ...